[ET Net News Agency, 20 June 2025] SINO BIOPHARM (01177) rose 2.9% to HK$4.99.
It hits an intra-day high of HK$5, and an intra-day low of HK$4.81. The total shares traded was 47.7 million, with a value of HK$235.42m. The active buy/sell ratio is 60:40, with net buying turnover of HK$48.23m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$10.16m, with volume weighted average price of HK$4.931. CLSA LTD accounts for greatest net responsive selling turnover of HK$10.78m, with volume weighted average price of HK$4.924.
The Hang Seng Index now rose 223 points, or 1% to 23,460.
Basic Information| Nominal | 4.990 | % Chg | +2.89% |
| High | 5.000 | Low | 4.810 |
| Shares Tr | 47.7m | Turnover | 235.42m |
| 10-D SMA | 5.039 | %H.V | 77.434 |
| 20-D SMA | 4.697 | VWAP | 4.935 |
| 50-D SMA | 4.169 | RSI14 | 59.997 |
Status: Active buy/sell ratio is 60:40, with net buying turnover of HK$48.23m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| SINO BIOPHARM (01177) | 4.99 | +2.89 |
| 3SBIO (01530) | 20.85 | Unchanged |
| EVEREST MED (01952) | 48.40 | +0.10 |
| WUXI XDC (02268) | 39.95 | +0.50 |
| ASCENTAGE-B (06855) | 71.00 | +0.57 |
| SKB BIO-B (06990) | 321.00 | -0.12 |
| ZAI LAB (09688) | 28.05 | +2.37 |
| AKESO (09926) | 91.65 | -0.43 |
| INNOCARE (09969) | 12.84 | -0.77 |
| REMEGEN (09995) | 50.90 | +2.00 |
(ed)
